Related Experiment Videos
Use of cardiovascular medications in the elderly
Jaffar Ali Raza1, Assad Movahed
1Section of Cardiology, Department of Medicine, The Brody School of Medicine, East Carolina University, Greenville, NC 27834-4354, USA.
Insights
Cardiovascular disease is a major concern for older adults. Understanding how aging affects drug metabolism and patient responses is crucial for effective cardiovascular medication use in the elderly.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- Cardiovascular disease (CVD) is the primary cause of mortality in individuals aged 65 and older.
- Elderly individuals account for a significant portion of national drug expenditures, despite representing a smaller percentage of the population.
- Appropriate cardiovascular medication use in the elderly can decrease morbidity and mortality rates.
Purpose of the Study:
- To highlight the importance of understanding age-related physiological changes.
- To emphasize the impact of these changes on cardiovascular drug efficacy and safety.
- To guide healthcare providers in optimizing cardiovascular pharmacotherapy for elderly patients.
Main Methods:
- Review of physiological and pharmacological changes associated with aging.
- Analysis of how aging affects drug metabolism and pharmacokinetics in the kidneys and liver.
- Examination of increased susceptibility to adverse drug reactions in the elderly population.
Main Results:
- Normal aging and disease processes induce significant structural and molecular alterations in elderly individuals.
- Changes in the autonomic nervous system, kidneys, and liver impact drug metabolism and clinical effects.
- Elderly patients exhibit heightened vulnerability to medication side effects and adverse drug reactions.
Conclusions:
- Physicians require a comprehensive understanding of aging processes and disease-related changes.
- Knowledge of altered drug pharmacology in the elderly is essential for safe and effective treatment.
- Optimizing cardiovascular care for the elderly necessitates a tailored approach to medication management.
Abstract:
Cardiovascular disease is the leading cause of death in patients aged 65 and above. Although elderly persons represent only 12.4% of the US population, they account for about a third of drug expenditures. However the appropriate use of cardiovascular medications in these patients has been shown to reduce the rate of cardiovascular morbidity and mortality. The normal aging and the disease process in the elderly result in significant changes at the structural and molecular level in the elderly. The changes that take place in the autonomic nervous system, the kidneys, and the liver in the elderly modify the metabolism and clinical effects of most medications. Elderly patients are also susceptible to side effects and adverse drug reactions. Physicians should have a clear understanding of the normal aging processes, the abnormal changes due to disease process and the changes in the pharmacology of drugs in the elderly to deliver proper care to the elderly patient.